Trikafta 50-25-37.5 MG/75 MG UU 84S
Ended Awarded Last action
- Contract number
- SPE2DR26FKKM1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,358
Award facts
- Contract value 100% obligated
- $19,357.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $19,357.71 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 50-25-37.5 mg/75 mg tablets (84-count units). The delivery order was issued on January 21, 2026, with an ultimate completion date of January 22, 2026, and carries no set-aside designation, indicating the award was made through open competition. This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was established on November 13, 2025, with a $499.999 billion ceiling and runs through December 31, 2036.
DMS Pharmaceutical Group serves as a critical pharmaceutical supplier within the Department of Defense's medical supply chain, leveraging its established capability to distribute branded and generic prescription medications, biologics, and specialized medical products to military healthcare facilities worldwide. The company's selection as a prime vendor under PPV-G GEN V—a $30.3 billion acquisition strategy—reflects its consistent performance in fulfilling diverse and specialized pharmaceutical requirements for federal military medical operations. As the sole contractor on this delivery order with no identified subcontractors, DMS Pharmaceutical Group demonstrates its direct delivery capacity for both routine and specialty pharmaceutical products essential to DoD healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FKKM1?
SPE2DR26FKKM1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FKKM1 worth?
The government has obligated $19,358 on SPE2DR26FKKM1.
Is contract SPE2DR26FKKM1 an order under another contract?
Yes. SPE2DR26FKKM1 is a delivery order under SPE2DR25D9367, an indefinite delivery contract.
Was contract SPE2DR26FKKM1 competed?
The extent of competition for SPE2DR26FKKM1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award